We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Medica 2024 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Blocked Membrane Translocators Initiate Cell Death Response

By LabMedica International staff writers
Posted on 04 Sep 2009
A team of molecular biologists has shown that certain antibiotics that kill bacteria by inhibiting protein transcription also cause the blockage and destruction of translocators, microtubules that transport macromolecules through organelle and cell membranes.

Investigators from Princeton University (NJ, USA) studied the Sec complex of translocators in Escherichia coli. They found that the antibiotics tetracycline and chloramphenicol, which inhibit ribosomal function, generated ribosome-polypeptide particles that became stuck in the translocators and plugged them up. In response, the cell activated the protease FtsH, which digested portions of the translocators and contributed to death of the cells. Increasing the amounts or the stability of the membrane protein YccA, a known inhibitor of FtsH, counteracted this destruction.

The findings from this bacterial system, which were published in the August 7, 2009, issue of the journal Science, may contribute to a better understanding of cancer therapeutics, since YccA is a functional homologue of the protooncogene product Bax inhibitor-1, which may share a similar mechanism of action in regulating apoptosis in mammalian cells.

"If we are to have any hope of outpacing the antibiotic resistance obtained by bacteria, it is paramount that we fully understand the mechanism of action of the antibiotics we currently use,” said first author Johna van Stelten, a graduate researcher in molecular biology at Princeton University. "Unfortunately, this is often very difficult as evidenced by the fact that, 50 years on, we are still learning new things about them. We have determined how YccA works in preventing stress-induced death in bacteria. We hope this new information will shed light on the mechanism of BI-1 in humans.”

Related Links:
Princeton University




New
Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Automated Blood Typing System
IH-500 NEXT
New
Automated Cell Counter
QuadCount
New
Quantitative Immunoassay Analyzer
AS050

Latest BioResearch News

Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns

Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma

New Method Simplifies Preparation of Tumor Genomic DNA Libraries